Skip to main content
Premium Trial:

Request an Annual Quote

Synthetic Gene Start-Up Sloning Raises $3.7M in VC Cash; Manufacturing Plant to Open 06

NEW YORK, July 8 (GenomeWeb News) - Synthetic gene company Sloning BioTechnology has raised €3.1 million ($3.7 million) in private equity, the company said.

 

The investment, originally made in May, was from Swiss VC shop HBM BioVentures and German company KFW Mittelstandsbank.

 

Sloning, based in Munich, Germany, said the cash will help it build its first production pant for synthetic genes. The plant, which will be developed with Accelab Laborautomations, is expected to be fully operational by mid-2006.

 

Additional details were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.